Johnson & Johnson refills drug cabinet with $30 billion Actelion deal
ALLSCHWIL, Switzerland (Reuters) - U.S. healthcare giant Johnson & Johnson will buy Swiss biotech company Actelion in a $30 billion all-cash deal that includes spinning off Actelion's research and... [Source]
Publication Date:Origin: reuters.com
Category: innovationNews
Topics: Johnson, Actelion, billion, research, Actelion's, spinning, includes, all-cash, company, biotech, Swiss, giant, healthcare, (Reuters), Switzerland, ALLSCHWIL, cabinet, refills
Source: http://feeds.reuters.com/~r/news/deals/~3/YY6GiKwFoj8/us-actelion-johnson-johnson-idUSKBN15A0KM